Schriftgröße ändern
  • Markets
  • News
  • Search
  • AA
Overview Chart Times&Sales News
Seagen 141.9300 / -0.64%
Date/Time 04/12 / 17:50
Chg. / Chg.(%) -0.9200 / -0.64%
Bid 141.8400 / 100
Ask 142.0400 / 200
Open 142.3100
Previous Close 142.8500
High 142.3500
Low 139.4600
Volume [USD] 32,208,122.8353
Volume [Units] 298,782
Price fixings 1203
ISIN US81181C1045
Security SGEN
Exchange NASDAQ
Type Stock

Other Exchanges

Exchange Last Volume
NASDAQ 141.9300 Kaum Veränd. zu Schluss Vort. 298,782
IEX 142.13 Kaum Veränd. zu Schluss Vort. 19,122
Cboe US 141.97 Kaum Veränd. zu Schluss Vort. 6,721
TradeGate 120.02 Kaum Veränd. zu Schluss Vort. 35
München 117.44 Diff. akt. K. - Schluss Vort. > -1% 0
Berlin 117.44 Diff. akt. K. - Schluss Vort. > -1% 0
Frankfurt 117.7600 Diff. akt. K. - Schluss Vort. > -1% 0
Stuttgart 119.680 Kaum Veränd. zu Schluss Vort.
Lang & Schwa.. 118.74 Kaum Veränd. zu Schluss Vort.
gettex 118.440 Diff. akt. K. - Schluss Vort. > -1%
Mexico 3,192.00 Diff. akt. K. - Schluss Vort. > -1% 21

News

  • Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
    04/09/2021 / 22:00 - GlobeNewswire
  •  
  • Fight Colorectal Cancer Urges Americans, “No Excuses! Get Screened!” after 10,000 excess cancer deaths are expected over the next decade
    03/02/2021 / 20:58 - GlobeNewswire
  •  
  • Genmab Publishes 2020 Annual Report
    02/23/2021 / 17:00 - GlobeNewswire
  •  
  • US opens lower ahead of economic updates
    02/12/2021 / 15:30 - TeleTrader
  •  
  • Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
    02/10/2021 / 22:05 - GlobeNewswire

Personal area

  • Add to watchlist
  •  
  • Add notification
  •  
  • Add to portfolio
  •  
  • Recommend Website

Market Overview>>

Currencies Real-time>>

Interest rates>>

Commodities>>

Futures>>

All quote information is delayed depending on the regulations of the selected stock exchange, in general 15 minutes or more. Terms of Use | Legal Notice | Recommend Website | Feedback | Go to full version (www.teletrader.com)